24 - Epidemiologically Important Multi-drug Resistant Organisms in Transplantation

Speaker(s)

• 

  Morgan Hakki, MD

  Associate Professor
  Infectious Diseases
  Oregon Health and Science University
  Portland, OR

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Mini Kamboj, MD

  CHIEF MEDICAL EPIDEMIOLOGIST
  MSKCC
  New York, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Stephanie Pouch, MD, MS, FAST

  Associate Professor of Medicine
  Emory University School of Medicine
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Learning Objectives:

• address controversies of transplanting candidates for SOT
• discuss issues with prophylaxis in transplant recipients, development of antimicrobial resistance and novel approaches to prevention of resistance development
• review current epidemiology of multidrug-resistant organisms in transplantation and methods to screen and prevent emergence in high risk patient populations

Presentations:

• 12:30pm – 1:45pm EDT

  Does Antibiotic Prophylaxis Drive Pseudomonas and Stenotrophomonas Infections in HCT?
  Morgan Hakki, MD – Oregon Health and Science University
• 12:30pm – 1:45pm EDT

  Should MDRO Screening of an International Donor/recipient Eligible for Transplantation Be Different?
  Mini Kamboj, MD – MSKCC
• 12:30pm – 1:45pm EDT

  Should We Transplant Patients with MDR Enterobacterales in SOT?
  Stephanie M. Pouch, MD, MS, FAST – Emory University School of Medicine